Sanctuary Advisors LLC raised its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 42.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 192,436 shares of the pharmacy operator’s stock after acquiring an additional 56,890 shares during the period. Sanctuary Advisors LLC’s holdings in CVS Health were worth $11,163,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the third quarter valued at approximately $25,000. Livelsberger Financial Advisory purchased a new stake in CVS Health during the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC bought a new position in shares of CVS Health during the 3rd quarter valued at $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health in the 3rd quarter worth $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health in the third quarter worth $33,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.
Analysts Set New Price Targets
Several research analysts have issued reports on CVS shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research note on Tuesday, December 3rd. TD Cowen upped their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Finally, Evercore ISI upped their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $70.50.
CVS Health Trading Down 0.4 %
CVS stock opened at $49.37 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a 1-year low of $48.01 and a 1-year high of $83.25. The business has a 50 day simple moving average of $58.34 and a two-hundred day simple moving average of $58.62. The company has a market capitalization of $62.13 billion, a price-to-earnings ratio of 12.53, a PEG ratio of 0.89 and a beta of 0.54.
CVS Health (NYSE:CVS – Get Free Report) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.21 earnings per share. Research analysts anticipate that CVS Health Co. will post 5.32 EPS for the current fiscal year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.39%. CVS Health’s dividend payout ratio is currently 67.51%.
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
- Five stocks we like better than CVS Health
- Stock Market Sectors: What Are They and How Many Are There?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- What is the Dogs of the Dow Strategy? Overview and Examples
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- How to Use the MarketBeat Excel Dividend Calculator
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.